搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Escherichia coli O139:H28 N-succinylglutamate 5-semialdehyde dehydrogenase (astD) CSB-YP419914EJD
CSB-EP419914EJD
CSB-BP419914EJD
CSB-MP419914EJD
CSB-EP419914EJD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O139:H28 Leucine efflux protein (leuE), partial CSB-YP419915EJD1
CSB-EP419915EJD1
CSB-BP419915EJD1
CSB-MP419915EJD1
CSB-EP419915EJD1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O139:H28 Copper homeostasis protein CutC (cutC) CSB-YP419916EJD
CSB-EP419916EJD
CSB-BP419916EJD
CSB-MP419916EJD
CSB-EP419916EJD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O139:H28 Protein dsrB (dsrB) CSB-YP419917EJD
CSB-EP419917EJD
CSB-BP419917EJD
CSB-MP419917EJD
CSB-EP419917EJD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O139:H28 ATP phosphoribosyltransferase (hisG) CSB-YP419918EJD
CSB-EP419918EJD
CSB-BP419918EJD
CSB-MP419918EJD
CSB-EP419918EJD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O139:H28 Putative multidrug resistance protein MdtD (mdtD), partial CSB-YP419919EJD
CSB-EP419919EJD
CSB-BP419919EJD
CSB-MP419919EJD
CSB-EP419919EJD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O139:H28 UPF0299 membrane protein yohJ (yohJ), partial CSB-YP419920EJD1
CSB-EP419920EJD1
CSB-BP419920EJD1
CSB-MP419920EJD1
CSB-EP419920EJD1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O139:H28 Nucleoid-associated protein YejK (yejK) CSB-YP419921EJD
CSB-EP419921EJD
CSB-BP419921EJD
CSB-MP419921EJD
CSB-EP419921EJD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O139:H28 Nucleoside triphosphatase nudI (nudI) CSB-YP419922EJD
CSB-EP419922EJD
CSB-BP419922EJD
CSB-MP419922EJD
CSB-EP419922EJD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O139:H28 Probable 4-amino-4-deoxy-L-arabinose-phosphoundecaprenol flippase subunit ArnF (arnF), partial CSB-YP419923EJD1
CSB-EP419923EJD1
CSB-BP419923EJD1
CSB-MP419923EJD1
CSB-EP419923EJD1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O139:H28 NADH-quinone oxidoreductase subunit C/D (nuoC) CSB-YP419924EJD
CSB-EP419924EJD
CSB-BP419924EJD
CSB-MP419924EJD
CSB-EP419924EJD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O139:H28 D-serine dehydratase (dsdA) CSB-YP419925EJD
CSB-EP419925EJD
CSB-BP419925EJD
CSB-MP419925EJD
CSB-EP419925EJD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O139:H28 Protein CysZ (cysZ), partial CSB-YP419926EJD1
CSB-EP419926EJD1
CSB-BP419926EJD1
CSB-MP419926EJD1
CSB-EP419926EJD1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O139:H28 UPF0370 protein ypfN (ypfN), partial CSB-YP419927EJD
CSB-EP419927EJD
CSB-BP419927EJD
CSB-MP419927EJD
CSB-EP419927EJD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O139:H28 GTPase Der (der) CSB-YP419928EJD
CSB-EP419928EJD
CSB-BP419928EJD
CSB-MP419928EJD
CSB-EP419928EJD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O139:H28 Chaperone protein hscA (hscA) CSB-YP419929EJD
CSB-EP419929EJD
CSB-BP419929EJD
CSB-MP419929EJD
CSB-EP419929EJD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O139:H28 3-phenylpropionate/cinnamic acid dioxygenase ferredoxin--NAD (+) reductase component CSB-YP419930EJD
CSB-EP419930EJD
CSB-BP419930EJD
CSB-MP419930EJD
CSB-EP419930EJD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O139:H28 tRNA1 (Val) (adenine (37)-N6)-methyltransferase CSB-YP419931EJD
CSB-EP419931EJD
CSB-BP419931EJD
CSB-MP419931EJD
CSB-EP419931EJD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O139:H28 Protein grpE (grpE) CSB-YP419932EJD
CSB-EP419932EJD
CSB-BP419932EJD
CSB-MP419932EJD
CSB-EP419932EJD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O139:H28 Carbon storage regulator (csrA) CSB-YP419933EJD
CSB-EP419933EJD
CSB-BP419933EJD
CSB-MP419933EJD
CSB-EP419933EJD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>